GridAI Technologies (GRDX) Short-Term Debt issuances (2023 - 2024)
GridAI Technologies' (GRDX) quarterly Short-Term Debt issuances came in at -$177563.0 in Q3 2024, down 15.69% on a YoY basis from -$210614.3 in Q4 2023, and up 26.32% quarter-over-quarter from -$241004.0 in Q2 2024.
Powered by 
Analysis
GridAI Technologies (GRDX) Short-Term Debt issuances (2023 - 2024) Analysis & Trends
GridAI Technologies (GRDX) has reported Short-Term Debt issuances for 2 consecutive years, with -$177563.0 the latest figure, recorded in Q3 2024.
- For the quarter ending Q3 2024, Short-Term Debt issuances fell 15.69% year-over-year to -$177563.0; the trailing twelve-month figure through Dec 2024 stood at -$644582.0 (changed N/A YoY), and the FY2025 full-year result was $700000.0, up 208.6% from the prior year.
- Short-Term Debt issuances advanced to -$177563.0 in Q3 2024 per GRDX's latest filing, from -$241004.0 in the prior quarter.
- Across five years, Short-Term Debt issuances topped out at -$153478.0 in Q3 2023 and bottomed at -$241004.0 in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -177,563.00 |
| Jun 30, 2024 | -241,004.00 |
| Mar 31, 2024 | -226,015.00 |
| Sep 30, 2023 | -153,478.00 |